Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture

Journal of Pineal Research

Volumn 39, Issue 3, 2005, Pages 266-275

  Vega Naredo, Ignacio ^a   Poeggeler, Burkhard ^b   Sierra Sánchez, Verónica ^a   Caballero, Beatriz ^a   Tomás Zapico, Cristina ^a   Álvarez García, Oscar ^a   Tolivia, Delio ^a   Rodríguez Colunga, María J ^a   Coto Montes, Ana ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antioxidant enzymes; Brain; Melatonin; Organ culture; Quinolinic acid; Rat

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE REDUCTASE; MELATONIN; PROTECTIVE AGENT; PROTEIN CARBONYL; QUINOLINIC ACID; SCAVENGER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN TISSUE; ENZYME ACTIVITY; HISTOPATHOLOGY; HORMONE ACTION; LIPID PEROXIDATION; MALE; MICROSCOPY; MORPHOLOGY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; TISSUE CULTURE;

EID: 25144451212     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00243.x     Document Type: Article

References (63)

1. REITER RJ. The melatonin message: duration versus coincidence hypotheses. Life Sci 1987; 40:2119-2131.
2. HARDELAND R, BALZER I, POEGGELER B et al. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res 1995; 18:104-111.
3. SHIDA CS, CASTRUCCI AML, LAMY-FREUND MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16:198-201.
4. COSTA EJ, LOPES RH, LAMY-FREUND MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res 1995; 19:123-126.
5. REITER RJ, MELCHIORRI D, SEWERYNEK E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11.
6. DUBOCOVICH ML, RIVERA-BERMUDEZ MA, GERDIN MJ et al. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 2003; 8:d1093-d1108.
7. ACUÑA-CASTROVIEJO D, PABLOS MI, MENÉNDEZ-PELAEZ A et al. Melatonin receptors in purified cell nuclei of liver. Res Commun Chem Pathol Pharmacol 1993; 82:253-256.
8. CARRILLO-VICO A, GARCÍA-PERGANEDA A, NAJI L et al. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell Mol Life Sci 2003; 60:2272-2278.
9. TOMÁS-ZAPICO C, BOGA JA, CABALLERO B et al. Coexpression of MT1 and RORα1 melatonin receptors in the syrian hamster Harderian gland. J Pineal Res 2005. DOI: 10.1111/j.1600-079x. 2005.00210.x.
10. RODRÍGUEZ C, MAYO JC, SÁINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
11. STONE TW. The neuropharmacology of quinolinic acid and kynurenic acids. Pharmacol Rev 1993; 45:309-379.
12. WOLFENSBERGER M, AMSLER U, CUENOD M et al. Identifications of quinolinic acid in rat and human brain tissue. Neurosci Lett 1983; 41:247-252.
13. MORONI F, LOMBARDI G, MONETI G et al. The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process. Neurosci Lett 1984; 47:51-55.
14. STONE TW, PERKINS MN. Quinolinic acid: a potent endogenous excitant at aminoacid receptors in CNS. Eur J Pharmacol 1981; 72:411-412.
15. PERKINS MN, STONE TW. The pharmacology and regional variations of quinolinic acid induced excitation in the rat CNS. J Pharmacol Exp Therap 1983; 226:551-557.
16. FERNANDES LEITE J. La enfermedad de Huntington una vision biomolecular. Rev Neurol 2001; 32:762-767.
17. CHOI DW. Excitotoxic cell death. J Neurobiol 1992; 23:1261-1276.
18. COYLE JT, PUTTFARCKEN P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262:689-695.
19. BELLE NA, DALMOLIN GD, FONINI G et al. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res 2004; 1008:245-251.
20. NAKAO N, BRUNDIN P. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 1997; 76:749-761.
21. SANTAMARÍA A, SALVATIERRA-SÁNCHEZ R, VÁZQUEZ- ROMÁN B et al. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem 2003; 86:479-488.
22. LEVI MS, BRIMBLE MA. A review of neuroprotective agents. Curr Med Chem 2004; 11:2383-2397.
23. GUPTA YK, GUPTA M, KOHLI K. Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian J Physiol Pharmacol 2003; 47:373-386.
24. LEÓN J, MACÍAS M, ESCAMES G et al. Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 2000; 58:967-975.
25. ALLEGRA M, REITER RJ, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
26. LIMA AC, LOUZADA PR, DE MELLO FG et al. Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptors involved? Neurotox Res 2003; 5:323-327.
27. ESCAMES G, ACUÑA-CASTROVIEJO D, LEÓN J et al. Melatonin interaction with magnesium and zinc in the response of the striatum to sensorimotor cortical stimulation in the rat. J Pineal Res 1998; 24:123-129.
28. ANDRABI SA, SAYEED I, SIEMEN D et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004; 18:869-871.
29. JOU MJ, PENG TI, REITER RJ et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37:55-70.
30. LEON J, ACUÑA-CASTROVIEJO D, ESCAMES G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38:1-9.
31. CABRERA J, REITER RJ, TAN DX et al. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neurophamacology 2000; 39:507-514.
32. STONE TW, BEHAN WM, MACDONALD M et al. Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species. Amino Acids 2000; 19:275-281.
33. CAZEVIEILLE C, SAFA R, OSBORNE NN. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res 1997; 768:120-124.
34. PLATENIK J, STOPKA P, VEJRAZKA M et al. Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction. Free Radic Res 2001; 34:445-459.
35. GODA K, KISHIMOTO R, SHIMIZU S et al. Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain. Adv Exp Med Biol 1996; 398:247-254.
36. SANTAMARÍA A, JIMÉNEZ-CAPDEVILLE ME, CAMACHO A et al. In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport 2001; 12:2693-2696.
37. ESTERBAUER H, CHEESEMAN KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186:407-421.
38. COTO-MONTES A, HARDELAND R. Diurnal time patterns of protein carbonyl in Drosophila melanogaster: comparison of wild-type flies and clock mutants. In: Biological Rhythms and Antioxidative Protection. Hardeland R, ed. Cuvillier, Göttingen, 1997; pp. 119-126.
39. LEVINE RL, GARLAND D, OLIVER CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186:464-478.
40. LUBINSKY S, BEWLEY GC. Genetics of catalase in Drosophila melanogaster: rates of synthesis and degradation of the enzyme in flies aneuploid and euploid for the structural gene. Genetics 1979; 91:723-742.
41. MARTIN JP Jr, DAILY M, SUGARMAN E. Negative and positive assays of superoxide dismutase based on hematoxylin oxidation. Arch Biochem Biophys 1987; 255:329-336.
42. KUM-TATT L, TAN IK, SEET AM. A new colorimetric method for the determination of NADH/NADPH dependent glutathione reductase in erythrocytes and in plasma. Clin Chim Acta 1975; 58:101-108.
43. BRADFORD MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
44. FLOYD RA, HENSLEY K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002; 23:795-807.
45. FLOYD RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222:236-245.
46. DELWING D, BAVARESCO CS, CHIARANI F et al. In vivo and in vitro effects of proline on some parameters of oxidative stress in rat brain. Brain Res 2003; 991:180-186.
47. TOMÁS-ZAPICO C, COTO-MONTES A, MARTÍNEZ-FRAGA J et al. Effects of delta-aminolevulinic acid and melatonin in the Harderian gland of female Syrian hamsters. Free Radic Biol Med 2002; 32:1197-1204.
48. REITER RJ, TAN DX, QI W et al. Pharmacology and physiology of melatonin in the reduction of oxidative stress. Biol Signals Recept 2000; 9:160-171.
49. REITER RJ, TAN DX, BURKHARDT S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002; 123:1007-1019.
50. URÍA H, FUHRBERG B, POEGGELER B et al. Photooxidation of melatonin. In: Cell Biological Problems in Chronobiology. Hardeland R, ed. Universität Göttingen, Göttingen, 1994; pp. 89-99.
51. CHANG HM, LING EA, CHEN CF et al. Melatonin attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats. J Pineal Res 2002; 32:65-73.
52. LEÓN J, VIVES F, CRESPO E et al. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J Neuroendocrinol 1998; 10:297-302.
53. TAVARES RG, TASCA CI, SANTOS CE et al. Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. Neuroreport 2000; 11:249-253.
54. RODRÍGUEZ-MARTÍNEZ E, CAMACHO A, MALDONADO PD et al. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res 2000; 858:436-439.
55. PÉREZ-SEVERIANO F, RODRÍGUEZ-PÉREZ M, PEDRAZA-CHAVERRI J et al. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 2004; 45:1175-1183.
56. POEGGELER B, THUERMANN S, DOSE A et al. Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs. J Pineal Res 2002; 33:20-30.
57. BRÖMME HJ, MÖRKE W, PESCHKE E et al. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 2000; 29:201-208.
58. TAN DX, MANCHESTER LC, REITER RJ et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998; 253:614-620.
59. HARDELAND R, COTO-MONTES A, POEGGELER B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int 2003; 20:921-962.
60. RESSMEYER AR, MAYO JC, ZELOSKO V et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003; 8:205-213.
61. ACUNA-CASTROVIEJO D, ESCAMES G, LEON J et al. Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2003; 527:549-557.
62. HARDELAND R, BURKHARDT S, ANTOLÍN I et al. Melatonin and 5-methoxytryptamine in the bioluminescent dinoflagellate Gonyaulax polyedra. In: Melatonin after Four Decades. Olcese J, ed. Kluwer Academic/Plenum Publishers, New York, 2000; pp. 387-390.
63. SANTAMARÍA A, PÉREZ-SEVERIANO F, RODRÍGUEZ- MARTÍNEZ E et al. Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease. Neurochem Res 2001; 26:419-424.